Posted by: Audrey Erbes | April 27, 2014

Pharma Company Elephants Dance Plus Events and Jobs

Big Pharma companies are playing high stakes game of swapping and selling off assets to improve the future of their product lines and company revenues and profitability. Pfizer is interested in acquiring AstraZeneca to boost its oncology pipeline. But the Astra Zeneca immunotherapy drugs are in early stage of development so it’s a high risk business initiative. See details of potential takeover which AstraZeneca isn’t interested in doing so far in article “AstraZeneca cancer pipeline seen as draw for Pfizer” by Ben Hirschler.

A large European company Novartis AG is thinking big by offloading their lower performing businesses and investing big in cancer. The goal is to increase operating income in the short term to overcome losses from Gleevec which will be going off patent. It’s selling its vaccine business to GSK and forming JV with them that is GSK majority owned. Novartis acquired GSK’s 11 marketed cancer drugs and one Phase II product. Other deals include Lilly’s purchase of the Novartis animal health business. Novartis’ outlay after the deals between the three giants, including upfront payments and near-term milestones, could reach $5.3 billion by the time the deals close.BioCentury has nice article entitled “Bigger is Better” April 28, 2014 detailing the deals. Also see Bloomberg article “Novartis to Buy Glaxo Cancer Drugs, Sell Animal Health” April 22, 2014.

Hopefully, the “opportunity assessments” behind these major business moves will be sound as they these transactions are sure to impact negatively on employment levels as the “elephants” dance.

  • BioCentury This Week, See new program Webcast Starting Sunday, April 27, 2014,, Available anytime starting at 9:00 a.m. EDT; Topic: “Profiles in Innovation: The Discovery of HCV Also Drug Supply Safety;” Speakers: Howard Sklamberg, Deputy Commissioner for Global Regulatory Operations and Policy at FDA and Gabrielle Cosel, Manager of the Pew Charitable Trusts’ Drug Safety Project; interview with Dr. Harvey Alter who discovered HCV.
  • Bio2Device Group, Tuesday Morning, April 29, 2014; Topic: “Developing Oncolytic Virus to Treat Glioblastoma,” Speaker: Michelle Chen, PhD, Chief Business Officer, DNAtrix
  • Thomson Reuters, Tuesday and Wednesday, April 29-30, 2014; Event: “Allicense 2014;” Confirmed speakers include…Ezekiel Emanuel, Wharton School & School of Medicine;       George Golumbeski, Celgene Corporation; Constantine Chinoporos, Sanofi;Fran Heller Bristol-Myers Squibb; Adam Feuerstein, TheStreet;Jeff Jonker, Theravance; James Mackay, AstraZeneca; Ari Fleischer, Former White House Press Secretary for U.S. President George W. Bush (see complete list at end of description)
  • Palo Alto AWIS, Tuesday Evening, April 29, 2014; Topic: “Women and Leadership,:Key Strategies to Build Trust and Credibility;” Speaker: Athena Williams, MA, Founder and CEO of The Leaders Studio
  • BayBio, Lunch and Learn, Friday Mid Day, April 30, 2014: Topic: “BayBio Lunch & Learn: FCPA: Risks of Doing Business Beyond Your Borders;” Speakers: Tammy Albarran, Eric Carlson, Haywood Gilliam
  • HBA, Thursday Morning, May 1, 2014;” Event: “Women of the Year”
  • MedTech Frontiers, Thursday Evening, May 1, 2014; Topic: “Operationalizing Health Data into Hyper-Personalized Care;” Speaker: Ash Damle, CEO and founder of Lumiata


Life Science Business Development Course: An Intensive Course June 19-20


This course which focuses on dealmaking, collaboration and alliances includes two days of intensive classes and then two months of project time with help of resources and access to BioCentury and Thomson Reuters Recap deal databases. See details at Registration is now open.


Find all the details for this coming week’s upcoming events plus those through June 2014 in Audrey’s Picks. You can download the pdf of Audreys Picks April 27, 2014

and JobsThatCrossedMyDeskThrough April 27 2014 by right clicking on the highlighted titles.


You can always find my weekly blog and listings at


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s


%d bloggers like this: